Table 2.
Methods | DLPFC |
BCDC |
Melanoma |
BRCA |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARI | NMI | HS | Purity | ARI | NMI | HS | Purity | ARI | NMI | HS | Purity | ARI | NMI | HS | Purity | |
stLearn [14] | 0.356 | 0.526 | 0.533 | 0.646 | 0.501 | 0.456 | 0.425 | 0.855 | - | - | - | - | 0.588 | 0.653 | 0.643 | 0.646 |
SEDR [19] | 0.499 | 0.643 | 0.631 | 0.725 | 0.187 | 0.077 | 0.083 | 0.799 | 0.281 | 0.389 | 0.418 | 0.754 | 0.485 | 0.660 | 0.644 | 0.566 |
SpaGCN [17] | 0.411 | 0.543 | 0.520 | 0.614 | 0.334 | 0.378 | 0.348 | 0.789 | 0.415 | 0.447 | 0.423 | 0.694 | 0.441 | 0.626 | 0.619 | 0.552 |
DeepST [20] | 0.476 | 0.620 | 0.606 | 0.689 | 0.459 | 0.389 | 0.354 | 0.838 | - | - | - | - | 0.546 | 0.680 | 0.663 | 0.642 |
STAGATE [18] | 0.501 | 0.645 | 0.624 | 0.727 | 0.442 | 0.337 | 0.319 | 0.836 | 0.410 | 0.438 | 0.418 | 0.719 | 0.460 | 0.688 | 0.666 | 0.561 |
STAMARKER [23] | 0.527 | 0.662 | 0.640 | 0.735 | 0.450 | 0.358 | 0.337 | 0.838 | 0.429 | 0.442 | 0.427 | 0.740 | 0.461 | 0.689 | 0.667 | 0.562 |
STMVGAE(ours) | 0.562 | 0.638 | 0.648 | 0.789 | 0.730 | 0.584 | 0.583 | 0.931 | 0.480 | 0.468 | 0.480 | 0.804 | 0.660 | 0.699 | 0.689 | 0.678 |